IBOV 166,334.86 ▼ 0.27% IPSA 11,186.57 ▲ 0.34% IPC MEX 64,301.04 ▲ 0.07% MERVAL 2,891,651 ▼ 1.89% COLCAP 2,461.23 ▲ 0.36% BVL PERÚ 58,401.58 ▼ 1.35% USD/BRL5.21▲ 0.22% USD/MXN17.06▲ 0.13% USD/CLP927.14▲ 1.17% USD/COP3,098▼ 1.01% USD/PEN3.37▼ 0.03% USD/ARS1,495▲ 0.45% USD/UYU40.26▲ 1.93% USD/PYG6,002▲ 2.02% USD/BOB11.48▲ 0.10% USD/DOP58.50▲ 1.26% USD/CRC444.65▲ 1.69% USD/GTQ7.62▲ 2.33% USD/HNL26.80▲ 1.74% USD/NIO36.62▲ 0.81% USD/VES771.38▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.71▲ 1.08% EUR/BRL6.03▼ 0.07% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 166,334.86 ▼ 0.27% IPSA 11,186.57 ▲ 0.34% IPC MEX 64,301.04 ▲ 0.07% MERVAL 2,891,651 ▼ 1.89% COLCAP 2,461.23 ▲ 0.36% BVL PERÚ 58,401.58 ▼ 1.35% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, August 18, 2026

Despite exemplary vaccinations, Chile becomes South American country with most new cases per million inhabitants

By · October 21, 2021 · 4 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Despite exemplary vaccination efforts, Chile has recently become the South American country with the most new Covid-19 cases per day per million inhabitants, a trend that seems unstoppable.

According to the El Mercurio newspaper, the corresponding rate in Chile is 67 diagnoses per day, which is more than Brazil (50), Uruguay (46), and almost double that of Bolivia (31).

In its report Wednesday, the Ministry of Health (Minsal) reported 1,206 infections and an increase of 49% and 61% compared to seven and 14 days, respectively.

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

Oxford University’s Our World in Data platform also documented this increase, with a rate of 70.65 cases per million population between Oct. 14 and 20.

IMMUNITY TO VACCINES IS NOT AS STRONG AS REQUIRED

If one asks for the reasons for this disappointing development, one hears from the local “experts”, as already for months, lame excuses like “people are not enough risk-conscious” and that the unvaccinated are to blame for it and similar long outdated thoughts.

Only because one repeats something constantly, it does not become therefore more true.

The truth, however, is probably much more shocking: We may have to get used to the fact that all claims that vaccination is the holy grail are not necessarily true.

Then Chile is only suffering the same fate as Israel, Iceland, Portugal, and others before them.

Israel was the first country in the world to fully vaccinate 69% of its 9.3 million residents over 16 years of age against Covid-19. The Pfizer/BioNTech vaccine distribution began in December 2020, and people were considered fully protected one week after the second injection.

However, in mid-August, it was reported that Israel had one of the highest daily infection rates in the world, doubling in just two weeks to an average of nearly 7,500 cases per day, meaning that almost one in 150 people is infected with the virus.

According to the Israeli Ministry of Health, the efficacy of two doses of the BNT162b2 vaccine (Pfizer-BioNTech) in preventing Covid-19 infection was 39%, well below the 96% efficacy found in the study.

It was also found that the immunity derived from the Pfizer-BioNTech vaccine may not have been as strong as required.

This meant that in August, half of the severely ill patients in Israel were those who had previously received double doses of the vaccine. The number of infections had increased tenfold from mid-July to mid-August, and reported deaths rose from 5 in June to 248 just two months later.

Of course, Israel was the first country to conduct a nationwide booster campaign with the third injection of Pfizer’s vaccine.

INCREASE IN INFECTIONS INDEPENDENT OF VACCINE LEVELS

What vaccine advocates might argue is meaningless when considering the results of a recent Harvard University study.

In 68 countries, including 2947 counties in the United States, they found that those vaccinated had a higher risk of Covid-19-related hospitalizations than those previously infected.

According to the research team, 60% of the Israeli population was fully vaccinated, and yet it had the most Covid-19 cases per 1 million people in the seven days before the study.

This was also the case in Iceland and Portugal, where more than 75% of the population was fully vaccinated. Still, there were more Covid-19 cases per 1 million population than in countries such as Vietnam and South Africa, where only about 10% of the population is fully vaccinated.

There is no valid argument for continuing to promote vaccines with false hope, let alone for coercing vaccinations through vaccination passports.

ALL IN FAVOR OF NATURAL IMMUNITY

Natural immunity should be considered at this point. Almost 30 scientific studies from around the world show that natural immunity provides effective protection against infection

Natural immunity to a SARS-type virus is robust, durable, and largely effective even in the case of mutations, generally more so than vaccines. The effort to pretend otherwise is a scientific betrayal, especially since the continued neglect of the subject is affecting the rights and freedoms of billions of people.

According to Monica Gandhi, Ph.D., many critical studies show us that memory B cells and memory T cells form in response to natural infection in infectious diseases. Studies one, two and three also show that these memory cells respond by producing antibodies to the available variants, indicating that booster vaccinations are unnecessary.

In a lengthy Twitter thread, Gandhi cited a list of about 20 references to natural immunity to covid that support the durability of vaccine- and infection-induced immunity and said he stopped adding articles in December because the list had become too long. But there’s more, as Gandhi says in a British Medical Journal article, “The studies keep coming.”

T-CELL IMMUNITY STILL STRONG AFTER 17 YEARS

The study, “SARS-CoV-2-specific T-cell immunity in COVID-19 and SARS cases and uninfected controls,” shows that those who recovered from SARS infection in 2002-03 are still strong 17 years later. However, antibodies are declining, indicating that T-cell immunity to coronaviruses is long-lasting. Gandhi points to a study showing that 32 people aged 91 to 101 who survived the 1918 influenza pandemic still had memory B cells capable of producing neutralizing antibodies against that strain nine decades later.

Yet these studies, which argue for natural immunity, are not considered by our governments, and to this day, vaccines are not only administered but are mandated.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.